Skip to main content

Table 4 Association between somatic symptom severity (PHQ-15) and EQ-5D

From: Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with somatoform disorders

  Number of patients with problems in EQ-5D item: EQ VAS Score EQ-5D Index UK EQ-5D Index D
Somatic symptom severity (PHQ-15) Mobility (%) a Self-care (%) a Usual Activity (%) a Pain/ Discomfort (%) a Anxiety/ Depression (%) a Mean (SD) Median Mean (SD) Median Mean (SD) Median
Minimal/ Low 14 (16.6%) 0 (0.00%) 22 (26.2%) 65 (77.4%) 44 (52.4%) 68.59 (18.75) 70 0.75 (0.16) 0.727 0.87 (0.14) 0.888
(0–9)
(n=84 / 29%)
Medium 32 (29.1%) 2 (1.80%) 54 (51.8%) 96 (87.3%) 72 (65.5%) 58.8 (18.54) 60 0.65 (0.24) 0.691 0.80 (0.2) 0.888
(10–14)
(n=110 / 37%)
High 38 (38.0%) 7 (7.00%) 63 (63.0%) 94 (94.0%) 79 (79.0%) 50.01 (18.72) 50 0.49 (0.32) 0.689 0.66 (0.3) 0.838
(15–30)
(n=100 / 34%)
p-value 0.006b 0.009b < 0.001b 0.004b 0.001b < 0.001c < 0.001c < 0.001c
  1. a Proportion of patients with problems according to the EQ-5D item in the group of patients with low / medium / high disease severity b Chi-square test; c Kruskal-Wallis test; This analysis is based on baseline data.